Unique ID issued by UMIN | UMIN000011480 |
---|---|
Receipt number | R000013436 |
Scientific Title | Standardization of Management during Pediatric Sedation for MRI : A Prospective Observational Study |
Date of disclosure of the study information | 2013/08/14 |
Last modified on | 2015/02/16 18:52:56 |
Standardization of Management during Pediatric Sedation for MRI
: A Prospective Observational Study
Standardization of Management during Pediatric Sedation for MRI
Standardization of Management during Pediatric Sedation for MRI
: A Prospective Observational Study
Standardization of Management during Pediatric Sedation for MRI
Japan |
Infants and children who need sedation for MRI
Pediatrics |
Others
NO
We investigate the efficacy of our protocol, which includes well-designed sedation regimes using oral triclofos sodium or rectal chloral hydrate and intravenous midazolam offered with risk management plans. Thereby, we are going to establish standardized sedation regimes and risk management systems including monitoring during pediatric sedation for MRI
Safety,Efficacy
Exploratory
Pragmatic
Phase II
The rate of successful sedation, which defined the number of successful sedation cases divided by all cases.
Criteria of the successful sedation
Little of no motion artifacts on the images judged by radiologists.
Completion of MRI within the maximum dosage of the sedative protocol.
The rate of successful sedation during the length of normal MRI examination, which we set 40 minutes.
Adverse events during sedation.
Dosages of sedatives, time from the administration of sedatives until the completion of the adequate sedation, the time to return to the normal state of awareness.
The delay of the start of MRI from the scheduled time.
The rate of acceptable images, which defined the number of acceptable sequences divided by the number of all sequences.
Possible correlation between successful sedation and patient characteristics
Observational
0 | years-old | <= |
6 | years-old | > |
Male and Female
Patients who require sedation for MRI judged by their doctors.
Informed written consent from the legal representatives for the participation of the study.
1 Class3 or 4 in ASA-Physical status
2 Class3 or 4 in Mallampaticlassification
3 Patients who have underlying disease with airway abnormality.
4 Patients with acute respiratory infection
5 Patients with known allergy to benzodiazepines or flumazenil
6 Patients on regular benzodiazepines
7 Previous participation of the study.
8 Patients who are assessed inappropriate for the study judged by the doctor in charge.
70
1st name | |
Middle name | |
Last name | Yukihiro Hasegawa |
Tokyo Metropolitan Childrens' Medical Center
General Medicine
2-8-29,Musashidai,Fuchu-city,Tokyo Metropolice,183-8561,JAPAN
042-300-5111
yukihiro_hasegawa@tmhp.jp
1st name | |
Middle name | |
Last name | Takuto Takahashi |
Tokyo Metropolitan Childrens' Medical Center
General Medicine
2-8-29,Musashidai,Fuchu-city,Tokyo Metropolice,183-8561,JAPAN
042-300-5111
http://www.byouin.metro.tokyo.jp/shouni/tiken/index_rinshoukenkyu.html
takuto_takahashi@tmhp.jp
Tokyo Metropolitan Childrens' Medical Center
Tokyo Metropolitan Childrens' Medical Center
Self funding
None
None
NO
東京都立小児総合医療センター(東京都)
2013 | Year | 08 | Month | 14 | Day |
Unpublished
Completed
2013 | Year | 06 | Month | 26 | Day |
2013 | Year | 08 | Month | 02 | Day |
2014 | Year | 05 | Month | 31 | Day |
None
2013 | Year | 08 | Month | 13 | Day |
2015 | Year | 02 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013436